Crossmark

Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma

Crossref DOI link: https://doi.org/10.1186/s13550-025-01262-2

Published Online: 2025-06-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Qingqing https://orcid.org/0000-0003-2815-0767
Chen, Zhenying

Liu, Silu

Zhang, Hongzhe

Feng, Jie

Miao, Weibing

Li, Fang

Cao, Xinxin

Luo, Yaping https://orcid.org/0000-0002-5787-1136
Funding

Funding for this research was provided by:

National High Level Hospital Clinical Research Funding (2022-PUMCH-B-070, 2022-PUMCH-B-071)

CAMS Innovation Fund for Medical Sciences (CIFMS, 2024-I2M-C&T-B-034)

Peking Union Medical College Hospital Talent Cultivation Program (UBJ10707)
License Information

Text and Data Mining valid from 2025-06-20

Version of Record valid from 2025-06-20
More Information

Article History

Received: 17 March 2025

Accepted: 14 May 2025

First Online: 20 June 2025

Declarations

:

: We performed this study in compliance with the 1964 Helsinki Declaration and its later amendments and federal laws in China. The study was approved by the Institutional Review Board in Peking Union Medical College Hospital and the First Affiliated Hospital, Fujian Medical University (ZS-1810, [2019]293) and registered at ClinicalTrials (NCT 03436342, 04504526).

: All patients signed written informed consent for the use of their data in this article.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below